pyrazines has been researched along with Hypertriglyceridemia in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 10 (66.67) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Anabuki, J; Fukuda-Tsuru, S; Ishii, S; Yoshida, K | 1 |
| Bjerve, KS; Grill, VE; Mostad, IL; Qvigstad, E | 1 |
| Andersen, R; Grinspoon, S; Hadigan, C; Liebau, J; Torriani, M | 1 |
| Vítková, D; Zák, A; Zeman, M | 1 |
| Ekstrand, A; Franssila-Kallunki, A; Groop, L; Saloranta, C; Taskinen, MR | 1 |
| Groop, L; Saloranta, C | 1 |
| Luley, C; Orth, M | 1 |
| Ho, LT; Hsiao, LC; Hwu, CM; Kwok, CF; Li, SH; Liu, YF; Shih, KC | 1 |
| Balogh, Z; Boda, J; Kárpáti, L; Kovács, P; Leövey, A; Paragh, G; Szabó, J | 1 |
| Ahsan, N; Beyer, KH; Korsunsky, Z; Vesell, ES | 1 |
| Hamood, H; Morad, N; Naschitz, J; Yeshurun, D | 1 |
| Bellosta, S; Bernini, F; Franceschini, G; Fumagalli, R; Michelagnoli, S; Pazzucconi, F; Sirtori, CR; Torre, C; Vaccarino, V | 1 |
| Bellosta, S; Bernini, F; Franceschini, G; Fumagalli, R; Michelagnoli, S; Sirtori, CR; Vaccarino, V | 1 |
| Bain, SC; Barnett, AH; Jones, AF | 1 |
| Cortese, C; Gnasso, A; Iannaci, G; Lamenza, F; Montefusco, S; Postiglione, A | 1 |
1 review(s) available for pyrazines and Hypertriglyceridemia
| Article | Year |
|---|---|
Interactions between glucose and FFA metabolism in man.
Topics: Animals; Biological Transport; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucose; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Insulin Resistance; Lipolysis; Models, Biological; Niacin; Obesity; Pyrazines | 1996 |
5 trial(s) available for pyrazines and Hypertriglyceridemia
| Article | Year |
|---|---|
Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia.
Topics: Adult; Body Composition; Double-Blind Method; Fatty Acids, Nonesterified; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Placebos; Pyrazines; Triglycerides | 2006 |
The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patients.
Topics: Fatty Acids, Nonesterified; Glucose; Glucose Clamp Technique; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Lipolysis; Male; Middle Aged; Oxidation-Reduction; Palmitates; Pyrazines | 1994 |
Acipimox attenuates hypertriglyceridemia in dyslipidemic noninsulin dependent diabetes mellitus patients without perturbation of insulin sensitivity and glycemic control.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Pyrazines; Triglycerides | 1997 |
Pyrazinoylguanidine in end-stage renal disease: a prospective, placebo-controlled pilot study.
Topics: Administration, Oral; Adult; Blood Glucose; Cholesterol; Female; Guanidines; Humans; Hyperglycemia; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Pyrazines; Renal Dialysis; Triglycerides | 1998 |
[Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia].
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents; Male; Middle Aged; Pyrazines; Triglycerides | 2000 |
9 other study(ies) available for pyrazines and Hypertriglyceridemia
| Article | Year |
|---|---|
A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations.
Topics: Adamantane; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Hyperglycemia; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Male; Nitriles; Pyrazines; Pyrazoles; Pyrrolidines; Rats; Rats, Wistar; Rats, Zucker; Sitagliptin Phosphate; Thiazolidines; Triazoles; Vildagliptin | 2012 |
Acute lowering of circulating fatty acids improves insulin secretion in a subset of type 2 diabetes subjects.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Dietary Proteins; Energy Intake; Exercise; Fasting; Fatty Acids; Female; Glucagon; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hyperglycemia; Hypertriglyceridemia; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Proinsulin; Pyrazines | 2003 |
[Comparison of the effects of omega-3 polyunsaturated fatty acids and Olbetam (Acipimox) in the treatment of hypertriglyceridemia].
Topics: Fatty Acids, Omega-3; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Middle Aged; Pyrazines | 1994 |
Diagnostic pitfalls during therapy for extreme hypertriglyceridaemia.
Topics: Adult; Cholesterol, LDL; Combined Modality Therapy; Docosahexaenoic Acids; Eicosapentaenoic Acid; Gemfibrozil; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Pyrazines; Triglycerides | 1997 |
Treatment possibility of hypercholesterolaemia associated with hypertriglyceridaemia.
Topics: Apolipoprotein A-I; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pyrazines; Time Factors; Triglycerides; Uric Acid | 1997 |
Increased affinity of LDL for their receptors after acipimox treatment in hypertriglyceridemia.
Topics: Adult; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pyrazines; Receptors, LDL | 1991 |
Lipoprotein changes and increased affinity of LDL for their receptors after acipimox treatment in hypertriglyceridemia.
Topics: Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins, LDL; Male; Pyrazines; Receptors, LDL | 1990 |
Acipimox and hypertriglyceridaemia.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Pyrazines | 1990 |
Blood and plasma viscosity after acipimox treatment in hypertriglyceridemic patients.
Topics: Adolescent; Adult; Blood Viscosity; Cholesterol; Female; Humans; Hypertriglyceridemia; Lipids; Male; Middle Aged; Pyrazines; Triglycerides | 1988 |